Long-Haul COVID-19 Emerges as a Concern, Potentially Increasing Need for More COVID-19 Antibody Testing
Clinical laboratories would test for COVID-19 antibodies in those with long-haul COVID-19 symptoms but are unsure if they were ever infected with SARS-CoV-2.
FDA Revokes EUA for a Monoclonal Antibody Treatment, Citing Its Ineffectiveness in Treating SARS-CoV-2 Variants
EUA revocation indicates that SARS-CoV-2 mutations are beginning to impact COVID-19 treatment efficacies.